Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells

Abstract Pulmonary vascular remodeling is a key pathological process of pulmonary arterial hypertension (PAH), characterized by uncontrolled proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs). Bortezomib (BTZ) is the first Food and Drug Administration (FDA)‐approved prote...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yi‐Ching Liu, Yu‐Hsin Tseng, Yu‐Hsin Kuan, Lin‐Yen Wang, Shang‐En Huang, Siao‐Ping Tsai, Jwu‐Lai Yeh, Jong‐Hau Hsu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2024-06-01
Ráidu:	Kaohsiung Journal of Medical Sciences
Fáttát:	bortezomib migration proliferation pulmonary arterial hypertension
Liŋkkat:	https://doi.org/10.1002/kjm2.12835
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!